
Prescription Drug Name:
Lidocaine 3% Cream
ID:
8451610e-eed9-4857-9171-938d00e307cf
Code:
34391-3
DESCRIPTION:
id: 507f497a-6033-455a-8927-05e2cba7b740
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3
anesthetic indicated for the relief of pruritus, pruritic
eczemas, abrasions, minor burns, insect bites, pain,
soreness, and discomfort due to pruritus ani, pruritus
vulvae, hemorrhoids, anal fissures, and similar conditions
of the skin and mucous membranes.
INDICATIONS:
id: 5ac88ed3-e5bb-4d84-a98d-38e8fca7219b
displayName: INDICATIONS & USAGE SECTION
FDA Article Code: 34067-9
eczemas, abrasions, minor burns, insect bites, pain,
soreness and discomfort due to pruritus ani, pruritus
vulvae, hemorrhoids, anal fissures, and similar conditions
of the skin and mucous membranes.
CONTRAINDICATIONS:
id: defb12f1-be5c-4c82-81e2-ab7faa384462
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3
area of proposed application and known hypersensitivity
to any of the components. Lidocaine is contraindicated in
patients with a known history of hypersensitivity to local
anesthetics of the amide type.
WARNINGS:
id: b0dcdb8d-a181-47e1-9bd8-1d48a3f9fe00
displayName: WARNINGS SECTION
FDA Article Code: 34071-1
PRECAUTIONS:
id: 1d7c6d92-676e-46eb-b43b-35116f3114be
displayName: PRECAUTIONS SECTION
FDA Article Code: 42232-9
infection appears, discontinue use and institute
appropriate therapy. Lidocaine 3% Cream should be used
with caution in ill, elderly, debilitated patients and
children who may be more sensitive to the systemic
effects of lidocaine.
CARCINOGENESIS, MUTAGENESIS, AND IMPAIRMENT OF FERTILITY:
id: 5fa59001-bf86-47f5-94ba-c2ab1c8ac364
displayName: CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION
FDA Article Code: 34083-6
carcinogenic and mutagenic potential of the effect on
fertility have not been conducted.
NURSING MOTHERS:
id: 679a0b8f-c495-4bee-98e9-7d29f1892c56
displayName: NURSING MOTHERS SECTION
FDA Article Code: 34080-2
significance of this observation is unknown. Caution
should be exercised when lidocaine is administered to a
nursing woman.
PEDIATRIC USE:
id: bd1bda71-bfcb-414a-8ef3-e8d059f94fbe
displayName: PEDIATRIC USE SECTION
FDA Article Code: 34081-0
ADVERSE REACTIONS:
id: 9b4b307a-2e5c-4967-9212-759855b8ad29
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4
of treatment may develop erythema or edema or may be
the locus of abnormal sensation.
CALL YOUR DOCTOR ABOUT SIDE EFFECTS.
id: 97c21641-cb35-4507-b013-35b5e7ff4347
displayName: SPL UNCLASSIFIED SECTION
FDA Article Code: 42229-5
DOSAGE AND ADMINISTRATION:
id: 75ebfc06-cc21-4b2a-85d6-5d9a751d0c0e
displayName: DOSAGE & ADMINISTRATION SECTION
FDA Article Code: 34068-7
HOW SUPPLIED:
id: 969fa2c6-3e0b-4643-939d-ade13f2c4933
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5
1 oz. (28.35 g) tubes, NDC 13925-159-01
3 oz. (85 g) tubes, NDC 13925-159-03.
KEEP THIS AND ALL MEDICATIONS OUT OF REACH OF CHILDREN.
id: b435f831-38de-4e16-8640-9cd4649d3474
displayName: STORAGE AND HANDLING SECTION
FDA Article Code: 44425-7
state statutes as applicable. This is not an Orange Book
product. This product may be administered only under a
physician’s supervision. There are no implied or explicit
claims on the therapeutic equivalence.
(59º-86º F). See USP Controlled Room Temperature.
Protect from freezing.
Seton Pharmaceuticals
Manasquan, NJ 08736
1-800-510-3401
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
id: 699628a4-c737-4050-9145-45bfe709327e
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4
Topical Anesthetic